paragon GmbH & Co. KGaA

  • WKN: 555869
  • ISIN: DE0005558696
  • Land: Deutschland

Nachricht vom 30.09.2021 | 18:32

Sales negotiations for stake in Voltabox concluded

DGAP-News: paragon GmbH & Co. KGaA / Key word(s): Disposal
30.09.2021 / 18:32
The issuer is solely responsible for the content of this announcement.

Sales negotiations for stake in Voltabox concluded

- Negotiations with investors successful - waiting for official exemption

- Buyer of Voltabox U.S. Activities confirms deal - signing of contract expected in next few days

- Revenue in automotive business still on track despite chip shortage

Delbrück, Germany, September 30, 2021 - paragon [ISIN DE0005558696] has successfully concluded negotiations with investors concerning the sale of the financial stake in Voltabox AG. Only an official exemption decision is still pending on the part of the buyer. Upon its receipt, an already negotiated purchase agreement will be concluded between paragon and an acquisition entity. The company expects the contract to be signed in October 2021.

In the meantime, agreement has also been reached with the buyer of Voltabox's U.S. activities, to be sold separately, on all key contractual points, which means this contract should also be concluded in the next few days. The sale of the U.S. activities would also have been a condition for the completion of the sale of the shares in Voltabox AG.

"We were able to reach consensus with both the buyer of our stake in Voltabox and with the buyer of Voltabox's U.S. activities almost simultaneously. We are very happy to have now created almost all the conditions for a successful completion of the process," says Klaus Dieter Frers, founder and CEO of paragon.

Meanwhile, the direct supplier to international car manufacturers is satisfied with the business performance in the automotive business. Despite the chip shortage, sales are on target and the forecast of € 145 million in sales and an EBITDA margin of 12% to 15% can be maintained.

Profile: paragon GmbH & Co. KGaA

paragon GmbH & Co. KGaA (ISIN DE0005558696), which is listed in the regulated market (Prime Standard) of the Frankfurt Stock Exchange, develops, produces and distributes forward-looking solutions in the field of automotive electronics, body kinematics and e-mobility. As a market-leading direct supplier to the automotive industry, the company's portfolio includes the Electronics operating segment's innovative air-quality management, state-of-the-art display systems and connectivity solutions, and high-end acoustic systems. In the Mechanics operating segment, paragon develops and produces active mobile aerodynamic systems. In addition, the Group holds a stake in Voltabox AG (ISIN DE000A2E4LE9), a subsidiary that is also listed on the regulated market (Prime Standard) of Deutsche Börse AG in Frankfurt a.M. and which is active in the electromobility segment with cutting-edge lithium-ion battery systems for industrial use developed inhouse. In the rapidly growing automotive market for battery systems and power electronics, paragon will operate on its own in the future.

In addition to the company headquarters in Delbrück (North Rhine-Westphalia, Germany), paragon GmbH & Co. KGaA and its subsidiaries operate sites in Suhl (Thuringia, Germany), Landsberg am Lech, Neu-Ulm and Nuremberg (Bavaria, Germany), St. Georgen (Baden-Württemberg, Germany), Limbach (Saarland, Germany), Aachen (North Rhine-Westphalia, Germany) as well as in Kunshan (China), Bangalore (India), Oroslavje (Croatia) and Austin (Texas, USA).

Additional information about paragon can be found at

Capital Market & Press Contact

paragon GmbH & Co. KGaA

Dr. Martin Esser
Bösendamm 11
33129 Delbrück, Germany
Phone: +49 (0) 52 50 - 97 62-200
Fax: +49 (0) 52 50 - 97 62-102

30.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021